Relationship Between Disability and Health-Related Quality of Life and Caregiver Burden in Patients With Upper Limb Poststroke Spasticity

PM and R

Volumn 4, Issue 1, 2012, Pages 4-10

  Doan, Quan V ^a   Brashear, Allison ^b   Gillard, Patrick J ^c   Varon, Sepideh F ^c   Vandenburgh, Amanda M ^c   Turkel, Catherine C ^c   Elovic, Elie P ^d  

^a Outcomes Insights Inc   (United States)

^b WAKE FOREST BAPTIST HEALTH   (United States)

^c ALLERGAN INC   (United States)

^d UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ADULT; AGED; ARTICLE; BANDAGES AND DRESSINGS; BODY POSTURE; CAREGIVER BURDEN; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DISABILITY ASSESSMENT SCALE; DISEASE ASSOCIATION; EUROQOL 5 DIMENSION; FEMALE; HUMAN; HYGIENE; INJURY SEVERITY; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PAIN ASSESSMENT; PHYSICIAN; POST HOC ANALYSIS; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; SCORING SYSTEM; SELF REPORT; SPASTICITY; UPPER LIMB POSTSTROKE SPASTICITY;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; AGED, 80 AND OVER; CAREGIVERS; DISABILITY EVALUATION; DISABLED PERSONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MUSCLE SPASTICITY; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; SICKNESS IMPACT PROFILE; STRESS, PSYCHOLOGICAL; STROKE; TIME FACTORS; YOUNG ADULT;

EID: 84856117015     PISSN: 19341482     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pmrj.2011.10.001     Document Type: Article

References (23)

1. Lloyd-Jones D., Adams R., Carnethon M., et al. Heart disease and stroke statistics-2009 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009, 119:480-486.
2. Sommerfeld D.K., Eek E.U., Svensson A.K., Holmqvist L.W., von Arbin M.H. Spasticity after stroke: Its occurrence and association with motor impairments and activity limitations. Stroke 2004, 35:134-139.
3. Watkins C.L., Leathley M.J., Gregson J.M., Moore A.P., Smith T.L., Sharma A.K. Prevalence of spasticity post stroke. Clin Rehabil 2002, 16:515-522.
4. Spasticity in adults: Management using botulinum toxin Royal College of Physisicans, Accessed August 5, 2010. http://www%20rcplondon%20ac%20uk/pubs/contents/6988a14a-1179-4071-8f56-dc2a865f0a43%20pdf.
5. van Exel N.J., Scholte op Reimer W.J., Koopmanschap M.A. Assessment of post-stroke quality of life in cost-effectiveness studies: The usefulness of the Barthel Index and the EuroQoL-5D. Qual Life Res 2004, 13:427-433.
6. Mayo N.E., Wood-Dauphinee S., Cote R., Durcan L., Carlton J. Activity, participation, and quality of life 6 months poststroke. Arch Phys Med Rehabil 2002, 83:1035-1042.
7. Sturm J.W., Donnan G.A., Dewey H.M., et al. Quality of life after stroke: The North East Melbourne Stroke Incidence Study (NEMESIS). Stroke 2004, 35:2340-2345.
8. Elovic E.P., Brashear A., Kaelin D., et al. Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients. Arch Phys Med Rehabil 2008, 89:799-806.
9. Caty G.D., Detrembleur C., Bleyenheuft C., Deltombe T., Lejeune T.M. Effect of upper limb botulinum toxin injections on impairment, activity, participation, and quality of life among stroke patients. Stroke 2009, 40:2589-2591.
10. Dolan P. Modeling valuations for EuroQol health states. Med Care 1997, 35:1095-1108.
11. van S.A., de Haan R.J., Limburg M., Schuling J., Bossuyt P.M., van den Bos G.A. A stroke-adapted 30-item version of the Sickness Impact Profile to assess quality of life (SA-SIP30). Stroke 1997, 28:2155-2161.
12. Niemi M.L., Laaksonen R., Kotila M., Waltimo O. Quality of life 4 years after stroke. Stroke 1988, 19:1101-1107.
13. King R.B. Quality of life after stroke. Stroke 1996, 27:1467-1472.
14. Buck D., Jacoby A., Massey A., Ford G. Evaluation of measures used to assess quality of life after stroke. Stroke 2000, 31:2004-2010.
15. Guidance for industry, patient-reported outcome measures: Use in medical product development to support labeling claims Food and Drug Administration, Accessed April, 1, 2011. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf.
16. Brashear A., Zafonte R., Corcoran M., et al. Inter- and intrarater reliability of the Ashworth Scale and the Disability Assessment Scale in patients with upper-limb poststroke spasticity. Arch Phys Med Rehabil 2002, 83:1349-1354.
17. EQ-5D User Guide: basic information on how to use EQ-5D EuroQol Group, Accessed October 21, 2011. http://www.euroqol.org/fileadmin/user_upload/Documenten/PDF/User_Guide_v2_March_2009.pdf.
18. Shaw J.W., Johnson J.A., Coons S.J. US valuation of the EQ-5D health states: Development and testing of the D1 valuation model. Med Care 2005, 43:203-220.
19. Xie J., Wu E.Q., Zheng Z.J., Sullivan P.W., Zhan L., Labarthe D.R. Patient-reported health status in coronary heart disease in the United States: Age, sex, racial, and ethnic differences. Circulation 2008, 118:491-497.
20. Pickard A.S., Neary M.P., Cella D. Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer. Health Qual Life Outcomes 2007, 5:70.
21. Shikiar R., Willian M.K., Okun M.M., Thompson C.S., Revicki D.A. The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: Results of a phase II study. Health Qual Life Outcomes 2006, 4:71.
22. Post P.N., Stiggelbout A.M., Wakker P.P. The utility of health states after stroke: A systematic review of the literature. Stroke 2001, 32:1425-1429.
23. Sullivan P.W., Lawrence W.F., Ghushchyan V. A national catalog of preference-based scores for chronic conditions in the United States. Med Care 2005, 43:736-749.